Latest Breaking News On - Opus genetics inc - Page 1 : comparemela.com

Ocular Therapeutix (OCUL) Appoints Adrienne L Graves to its Board

Ocular Therapeutix (OCUL) Appoints Adrienne L Graves to its Board
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesFrance generalAntony mattessichInvestorsocular therapeutixdonald notmanchiefMediaicr westwickeben shannonAerpio therapeutics incGlaucoma research foundationEncore vision incNvasc incFoundation fighting blindnessTheroptix incUniversity of michiganWorldwide clinical developmentInternational ophthalmologyEnvisia therapeutics incSurface ophthalmics inc

Ocular Therapeutix™ Announces Appointment of New Board Member

BEDFORD, Mass., July 12, 2023 Ocular Therapeutix, Inc. , a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and.

France generalUnited statesAntony mattessichBen shannonDonald notmanChris brinzeyFoundation boardsAerpio therapeutics incNvasc incUniversity of parisEnvisia therapeutics incEncore vision incAkorn incQlaris bio incRetinal electrophysiology laboratoryTheroptix inc

Iveric Bio Reports Fourth Quarter and Full Year 2022 Operational Highlights and Financial Results

Iveric Bio Reports Fourth Quarter and Full Year 2022 Operational Highlights and Financial Results
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomPravinu dugelKathy galanteIveric bioJeannie neufeldGlennp sblendorioSilicon valley bankCompany phaseOpus genetics incAdvisory committeeExchange commissionPublic relations communicationsWhile the companyHealthcare products agencyEuropean medicines agency

IVERIC bio (ISEE) to sell IC-100 and IC-200 for treatment of certain inherited retinal diseases to Opus Genetics

IVERIC bio (ISEE) to sell IC-100 and IC-200 for treatment of certain inherited retinal diseases to Opus Genetics
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Opus genetics incUniversity of florida research foundation incorporatedTrustees of the university pennsylvania pennGene therapyWall streetAsset purchase agreementOpus geneticsIveric subsidiaryPurchase agreementSeries seed preferred stockStock issuance agreementExclusive license agreementFlorida research foundationAnnual report

IVERIC bio (ISEE) to sell IC-100 and IC-200 for treatment of certain inherited retinal diseases to Opus Genetics

Opus genetics incUniversity of florida research foundation incorporatedTrustees of the university pennsylvania pennGene therapyAsset purchase agreementOpus geneticsIveric subsidiaryPurchase agreementSeries seed preferred stockStock issuance agreementExclusive license agreementFlorida research foundationAnnual report